FdaApplication
ANDA 213079
Identifiers
- fda_app_no: ANDA213079
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-04-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAZAROTENE | TAZAROTENE | 0.1% | GEL;TOPICAL |
| TAZAROTENE | TAZAROTENE | 0.05% | GEL;TOPICAL |
2 products